Dutch cancer testing lab reinforces credibility with ISO/IEC 17025:2005 accreditation

摘要

Agendia B.V., the world's first diagnostic microarray lab to obtain ISO/IEC 17025 accreditation for its breast cancer testing activities, implemented the standard from start up in 2003. Now its increased credibility as a profiling service has led to easier discussions with governmental bodies and potential partners. On 29 June 2005, Agendia B.V. was awarded accreditation to ISO/IEC 17025:1999, General requirements for the competence of testing and calibration laboratories, for its MammaPrint gene expression profiling service, making it the world's first gene expression microarray laboratory to be granted the distinction.